▶ 調査レポート

世界の線維肉腫の治療市場:市場規模・現状・予測

• 英文タイトル:Global Fibrosarcoma Treatment Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の線維肉腫の治療市場:市場規模・現状・予測 / Global Fibrosarcoma Treatment Market Size, Status and Forecast 2019-2025 / QYR9N7207資料のイメージです。• レポートコード:QYR9N7207
• 出版社/出版日:QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、93ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医療・製薬・バイオ
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当資料は、線維肉腫の治療のグローバル市場について調査・分析したレポートで、種類別(化学療法、放射線療法、手術、その他)、用途別(病院、診療所、専門がん治療センター、その他)、主要地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米)の市場規模、市場予測、関連企業情報などが含まれています。

・線維肉腫の治療の世界市場規模
・主要企業別市場シェア
・線維肉腫の治療の世界市場規模:種類別(化学療法、放射線療法、手術、その他)
・線維肉腫の治療の世界市場規模:用途別(病院、診療所、専門がん治療センター、その他)
・線維肉腫の治療のアメリカ市場規模(種類別、用途別)
・線維肉腫の治療のヨーロッパ市場規模(種類別、用途別)
・線維肉腫の治療の中国市場規模(種類別、用途別)
・線維肉腫の治療の日本市場規模(種類別、用途別)
・線維肉腫の治療の東南アジア市場規模(種類別、用途別)
・線維肉腫の治療のインド市場規模(種類別、用途別)
・線維肉腫の治療の中南米市場規模(種類別、用途別)
・主要企業別分析(企業概要、製品動向、販売量など)
・線維肉腫の治療の世界市場予測(2019年-2025年)
・線維肉腫の治療の地域別市場予測(2019年-2025年)
...

Fibrosarcoma is cancer, which is a part of larger collection of cancers known as sarcomas. Fibrosarcoma is generally treated with the help of chemotherapy.In 2018, the global Fibrosarcoma Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Fibrosarcoma Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Fibrosarcoma Treatment development in United States, Europe and China.

The key players covered in this study
Pfizer
Novartis
Johnson & Johnson
Bristol-Myers Squibb
Eli Lilly
Baxter International
Sun Pharmaceutical
Cadila Pharmaceuticals
Celon Laboratories
Dr. Reddy’s Laboratories

Market segment by Type, the product can be split into
Chemotherapy
Radiation Therapy
Surgery
Others

Market segment by Application, split into
Hospitals
Clinics
Specialized Cancer Treatment Centers
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Fibrosarcoma Treatment status, future forecast, growth opportunity, key market and key players.
To present the Fibrosarcoma Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Fibrosarcoma Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Fibrosarcoma Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Chemotherapy
1.4.3 Radiation Therapy
1.4.4 Surgery
1.4.5 Others
1.5 Market by Application
1.5.1 Global Fibrosarcoma Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Specialized Cancer Treatment Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Fibrosarcoma Treatment Market Size
2.2 Fibrosarcoma Treatment Growth Trends by Regions
2.2.1 Fibrosarcoma Treatment Market Size by Regions (2014-2025)
2.2.2 Fibrosarcoma Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Fibrosarcoma Treatment Market Size by Manufacturers
3.1.1 Global Fibrosarcoma Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Fibrosarcoma Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Fibrosarcoma Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Fibrosarcoma Treatment Key Players Head office and Area Served
3.3 Key Players Fibrosarcoma Treatment Product/Solution/Service
3.4 Date of Enter into Fibrosarcoma Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Fibrosarcoma Treatment Market Size by Type (2014-2019)
4.2 Global Fibrosarcoma Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Fibrosarcoma Treatment Market Size (2014-2019)
5.2 Fibrosarcoma Treatment Key Players in United States
5.3 United States Fibrosarcoma Treatment Market Size by Type
5.4 United States Fibrosarcoma Treatment Market Size by Application

6 Europe
6.1 Europe Fibrosarcoma Treatment Market Size (2014-2019)
6.2 Fibrosarcoma Treatment Key Players in Europe
6.3 Europe Fibrosarcoma Treatment Market Size by Type
6.4 Europe Fibrosarcoma Treatment Market Size by Application

7 China
7.1 China Fibrosarcoma Treatment Market Size (2014-2019)
7.2 Fibrosarcoma Treatment Key Players in China
7.3 China Fibrosarcoma Treatment Market Size by Type
7.4 China Fibrosarcoma Treatment Market Size by Application

8 Japan
8.1 Japan Fibrosarcoma Treatment Market Size (2014-2019)
8.2 Fibrosarcoma Treatment Key Players in Japan
8.3 Japan Fibrosarcoma Treatment Market Size by Type
8.4 Japan Fibrosarcoma Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Fibrosarcoma Treatment Market Size (2014-2019)
9.2 Fibrosarcoma Treatment Key Players in Southeast Asia
9.3 Southeast Asia Fibrosarcoma Treatment Market Size by Type
9.4 Southeast Asia Fibrosarcoma Treatment Market Size by Application

10 India
10.1 India Fibrosarcoma Treatment Market Size (2014-2019)
10.2 Fibrosarcoma Treatment Key Players in India
10.3 India Fibrosarcoma Treatment Market Size by Type
10.4 India Fibrosarcoma Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Fibrosarcoma Treatment Market Size (2014-2019)
11.2 Fibrosarcoma Treatment Key Players in Central & South America
11.3 Central & South America Fibrosarcoma Treatment Market Size by Type
11.4 Central & South America Fibrosarcoma Treatment Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Fibrosarcoma Treatment Introduction
12.1.4 Pfizer Revenue in Fibrosarcoma Treatment Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Fibrosarcoma Treatment Introduction
12.2.4 Novartis Revenue in Fibrosarcoma Treatment Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Company Details
12.3.2 Company Description and Business Overview
12.3.3 Fibrosarcoma Treatment Introduction
12.3.4 Johnson & Johnson Revenue in Fibrosarcoma Treatment Business (2014-2019)
12.3.5 Johnson & Johnson Recent Development
12.4 Bristol-Myers Squibb
12.4.1 Bristol-Myers Squibb Company Details
12.4.2 Company Description and Business Overview
12.4.3 Fibrosarcoma Treatment Introduction
12.4.4 Bristol-Myers Squibb Revenue in Fibrosarcoma Treatment Business (2014-2019)
12.4.5 Bristol-Myers Squibb Recent Development
12.5 Eli Lilly
12.5.1 Eli Lilly Company Details
12.5.2 Company Description and Business Overview
12.5.3 Fibrosarcoma Treatment Introduction
12.5.4 Eli Lilly Revenue in Fibrosarcoma Treatment Business (2014-2019)
12.5.5 Eli Lilly Recent Development
12.6 Baxter International
12.6.1 Baxter International Company Details
12.6.2 Company Description and Business Overview
12.6.3 Fibrosarcoma Treatment Introduction
12.6.4 Baxter International Revenue in Fibrosarcoma Treatment Business (2014-2019)
12.6.5 Baxter International Recent Development
12.7 Sun Pharmaceutical
12.7.1 Sun Pharmaceutical Company Details
12.7.2 Company Description and Business Overview
12.7.3 Fibrosarcoma Treatment Introduction
12.7.4 Sun Pharmaceutical Revenue in Fibrosarcoma Treatment Business (2014-2019)
12.7.5 Sun Pharmaceutical Recent Development
12.8 Cadila Pharmaceuticals
12.8.1 Cadila Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Fibrosarcoma Treatment Introduction
12.8.4 Cadila Pharmaceuticals Revenue in Fibrosarcoma Treatment Business (2014-2019)
12.8.5 Cadila Pharmaceuticals Recent Development
12.9 Celon Laboratories
12.9.1 Celon Laboratories Company Details
12.9.2 Company Description and Business Overview
12.9.3 Fibrosarcoma Treatment Introduction
12.9.4 Celon Laboratories Revenue in Fibrosarcoma Treatment Business (2014-2019)
12.9.5 Celon Laboratories Recent Development
12.10 Dr. Reddy’s Laboratories
12.10.1 Dr. Reddy’s Laboratories Company Details
12.10.2 Company Description and Business Overview
12.10.3 Fibrosarcoma Treatment Introduction
12.10.4 Dr. Reddy’s Laboratories Revenue in Fibrosarcoma Treatment Business (2014-2019)
12.10.5 Dr. Reddy’s Laboratories Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Fibrosarcoma Treatment Key Market Segments
Table Key Players Fibrosarcoma Treatment Covered
Table Global Fibrosarcoma Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Fibrosarcoma Treatment Market Size Market Share by Type 2014-2025
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Radiation Therapy Figures
Table Key Players of Radiation Therapy
Figure Surgery Figures
Table Key Players of Surgery
Figure Others Figures
Table Key Players of Others
Table Global Fibrosarcoma Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Specialized Cancer Treatment Centers Case Studies
Figure Others Case Studies
Figure Fibrosarcoma Treatment Report Years Considered
Table Global Fibrosarcoma Treatment Market Size 2014-2025 (Million US$)
Figure Global Fibrosarcoma Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Fibrosarcoma Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Fibrosarcoma Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Fibrosarcoma Treatment Market Share by Regions 2014-2019
Figure Global Fibrosarcoma Treatment Market Share by Regions 2014-2019
Figure Global Fibrosarcoma Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Fibrosarcoma Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Fibrosarcoma Treatment Market Share by Manufacturers (2014-2019)
Figure Global Fibrosarcoma Treatment Market Share by Manufacturers in 2018
Table Global Fibrosarcoma Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Fibrosarcoma Treatment Product/Solution/Service
Table Date of Enter into Fibrosarcoma Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Fibrosarcoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Fibrosarcoma Treatment Market Size Share by Type (2014-2019)
Figure Global Fibrosarcoma Treatment Market Size Market Share by Type (2014-2019)
Table Global Fibrosarcoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Fibrosarcoma Treatment Market Size Share by Application (2014-2019)
Figure Global Fibrosarcoma Treatment Market Size Market Share by Application (2014-2019)
Figure Global Fibrosarcoma Treatment Revenue Market Share by Application in 2018
Figure United States Fibrosarcoma Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Fibrosarcoma Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Fibrosarcoma Treatment Market Share (2018-2019)
Table United States Fibrosarcoma Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Fibrosarcoma Treatment Market Share by Type (2014-2019)
Table United States Fibrosarcoma Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Fibrosarcoma Treatment Market Share by Application (2014-2019)
Figure Europe Fibrosarcoma Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Fibrosarcoma Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Fibrosarcoma Treatment Market Share (2018-2019)
Table Europe Fibrosarcoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Fibrosarcoma Treatment Market Share by Type (2014-2019)
Table Europe Fibrosarcoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Fibrosarcoma Treatment Market Share by Application (2014-2019)
Figure China Fibrosarcoma Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Fibrosarcoma Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Fibrosarcoma Treatment Market Share (2018-2019)
Table China Fibrosarcoma Treatment Market Size by Type (2014-20189) (Million US$)
Table China Fibrosarcoma Treatment Market Share by Type (2014-2019)
Table China Fibrosarcoma Treatment Market Size by Application (2014-2019) (Million US$)
Table China Fibrosarcoma Treatment Market Share by Application (2014-2019)
Figure Japan Fibrosarcoma Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Fibrosarcoma Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Fibrosarcoma Treatment Market Share (2018-2019)
Table Japan Fibrosarcoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Fibrosarcoma Treatment Market Share by Type (2014-2019)
Table Japan Fibrosarcoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Fibrosarcoma Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Fibrosarcoma Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Fibrosarcoma Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Fibrosarcoma Treatment Market Share (2018-2019)
Table Southeast Asia Fibrosarcoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Fibrosarcoma Treatment Market Share by Type (2014-2019)
Table Southeast Asia Fibrosarcoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Fibrosarcoma Treatment Market Share by Application (2014-2019)
Figure India Fibrosarcoma Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Fibrosarcoma Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Fibrosarcoma Treatment Market Share (2018-2019)
Table India Fibrosarcoma Treatment Market Size by Type (2014-2019) (Million US$)
Table India Fibrosarcoma Treatment Market Share by Type (2014-2019)
Table India Fibrosarcoma Treatment Market Size by Application (2014-2019) (Million US$)
Table India Fibrosarcoma Treatment Market Share by Application (2014-2019)
Figure Central & South America Fibrosarcoma Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Fibrosarcoma Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Fibrosarcoma Treatment Market Share (2018-2019)
Table Central & South America Fibrosarcoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Fibrosarcoma Treatment Market Share by Type (2014-2019)
Table Central & South America Fibrosarcoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Fibrosarcoma Treatment Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Fibrosarcoma Treatment Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Fibrosarcoma Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Novartis Company Details
Table Novartis Revenue in Fibrosarcoma Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Fibrosarcoma Treatment Business (2014-2019)
Table Novartis Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Fibrosarcoma Treatment Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Fibrosarcoma Treatment Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Fibrosarcoma Treatment Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Fibrosarcoma Treatment Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Fibrosarcoma Treatment Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Fibrosarcoma Treatment Business (2014-2019)
Table Eli Lilly Recent Development
Table Baxter International Company Details
Table Baxter International Revenue in Fibrosarcoma Treatment Business (2014-2019)(Million US$)
Figure Baxter International Revenue Growth Rate in Fibrosarcoma Treatment Business (2014-2019)
Table Baxter International Recent Development
Table Sun Pharmaceutical Company Details
Table Sun Pharmaceutical Revenue in Fibrosarcoma Treatment Business (2014-2019)(Million US$)
Figure Sun Pharmaceutical Revenue Growth Rate in Fibrosarcoma Treatment Business (2014-2019)
Table Sun Pharmaceutical Recent Development
Table Cadila Pharmaceuticals Company Details
Table Cadila Pharmaceuticals Revenue in Fibrosarcoma Treatment Business (2014-2019)(Million US$)
Figure Cadila Pharmaceuticals Revenue Growth Rate in Fibrosarcoma Treatment Business (2014-2019)
Table Cadila Pharmaceuticals Recent Development
Table Celon Laboratories Company Details
Table Celon Laboratories Revenue in Fibrosarcoma Treatment Business (2014-2019)(Million US$)
Figure Celon Laboratories Revenue Growth Rate in Fibrosarcoma Treatment Business (2014-2019)
Table Celon Laboratories Recent Development
Table Dr. Reddy's Laboratories Company Details
Table Dr. Reddy's Laboratories Revenue in Fibrosarcoma Treatment Business (2014-2019)(Million US$)
Figure Dr. Reddy's Laboratories Revenue Growth Rate in Fibrosarcoma Treatment Business (2014-2019)
Table Dr. Reddy's Laboratories Recent Development
Table Global Fibrosarcoma Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Fibrosarcoma Treatment Market Size Share by Regions (2019-2025)
Figure Global Fibrosarcoma Treatment Market Size Share by Regions in 2025
Figure United States Fibrosarcoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Fibrosarcoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Fibrosarcoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Fibrosarcoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Fibrosarcoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Fibrosarcoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Fibrosarcoma Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Fibrosarcoma Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Fibrosarcoma Treatment Market Size by Product (2019-2025)
Figure Global Fibrosarcoma Treatment Market Size by Product in 2025
Table Global Fibrosarcoma Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Fibrosarcoma Treatment Market Size by Application (2019-2025)
Figure Global Fibrosarcoma Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources